EUVIMEDEUVIMED entdecken
Crossref

Biomimetic Nanodrug Prepared by Cell Exocytosis Induces Cancer Stem Cell Differentiation by Attenuating Wnt Signaling Pathway

Juncai Zhang, Jinchao Zhang iD, Leyao Kang, Feichi Wang, Hongyuan Hao, Meng Jiao, Xing-Jie Liang, Dandan Liu

Advanced Healthcare Materials · 2025

DOI: 10.1002/adhm.202500778 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Juncai Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of New Pharmaceutical Preparations and Excipients, Key Laboratory of Medicinal Chemistry and Molecular Diagnosis of the Ministry…. Hauptthemen laut MEDLINE: Neoplastic Stem Cells, Wnt Signaling Pathway, Cell Differentiation, Nanoparticles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundations of China, Science Fund for Creative Research Groups of Nature Science Foundation of Hebei Province, Hebei Province Higher Education Science and Technology Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer stem cells (CSCs) represent a critical therapeutic target due to their role in chemoresistance and tumor recurrence. Targeting CSCs based on their distinct differentiation ability is a brilliant cancer therapeutic strategy. Although a few small‐molecule and nanomaterial‐based differentiation inducers have been reported, their limited specificity raises concerns about off‐target effects, particularly the unintended differentiation of normal stem cells. Recently, mesenchymal stem cell‐derived exosomes (MSC‐exos) have come into focus as drug carriers as they retain parental properties that can alter functionality of CSCs types and produce mature tumor cells. Herein, an in situ biosynthetic MSC‐exos‐based nanodrug (E‐DDP@MSNs) have been developed by incubating MSCs with cisplatin‐loaded mesoporous silica nanoparticles, which are then isolated from the cell culture medium by ultracentrifugation. In contrast to the electroporation, E‐DDP@MSNs retain the exosomal contents more completely without significant leakage that can promote the CSCs to differentiate into mature tumor cells, which are more susceptible to chemotherapy. Mechanistically, E‐DDP@MSN promotes the differentiation of CSCs by transporting exosomal DKK‐1 into CSCs, thereby causing attenuation of the Wnt pathway that is essential in maintaining stemness, self‐renewal, and tumorigenicity of CSCs. In summary, E‐DDP@MSNs represent a promising approach for CSC‐targeted differentiation therapy, offering high efficacy with minimal toxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplastic Stem CellsWnt Signaling PathwayCell DifferentiationNanoparticlesExocytosisBiomimetic MaterialsHumansCisplatinExosomesAnimalsMesenchymal Stem CellsSilicon DioxideMiceCell Line, TumorAntineoplastic AgentsBiomimetics

Stichwörter der Autor:innen

cancer stem celldifferentiation therapyexosomemesenchymal stem cellnano vehicle

Substanzen

CisplatinSilicon DioxideAntineoplastic Agents

Autor:innen und Institutionen

  • State Key Laboratory of New Pharmaceutical Preparations and Excipients, Key Laboratory of Medicinal Chemistry and Molecular Diagnosis of the Ministry of Education, Laboratory of Chemical Biology of Hebei Province & Coll…
  • Department of Radiotherapy, Affiliated Hospital of Hebei University, Baoding, 071000, P. R. China.
  • CAS Center for Excellence in Nanoscience, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology, Beijing, 100190, P. R. China.

ORCID-Profile: Jinchao Zhang

Förderung

  • National Natural Science Foundations of China
  • Science Fund for Creative Research Groups of Nature Science Foundation of Hebei Province
  • Hebei Province Higher Education Science and Technology Research Project
  • The central government-guided special funds for local scientific and technological development
  • Hebei Youth Top Talent Project
  • The Research and Innovation Team of Hebei University
  • Hebei Province Innovation Capability Enhancement Plan Project
  • Health Commission of Hebei Province

Zitieren

APA

Zhang, J., Zhang, J., Kang, L., Wang, F., Hao, H., Jiao, M., Liang, X. J., & Liu, D. (2025). Biomimetic Nanodrug Prepared by Cell Exocytosis Induces Cancer Stem Cell Differentiation by Attenuating Wnt Signaling Pathway. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202500778

Vancouver

Zhang J, Zhang J, Kang L, Wang F, Hao H, Jiao M, et al. Biomimetic Nanodrug Prepared by Cell Exocytosis Induces Cancer Stem Cell Differentiation by Attenuating Wnt Signaling Pathway. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202500778

BibTeX
@article{Zhang2025,
  author = {Zhang, Juncai and Zhang, Jinchao and Kang, Leyao and Wang, Feichi and Hao, Hongyuan and Jiao, Meng and Liang, Xing-Jie and Liu, Dandan},
  title = {Biomimetic Nanodrug Prepared by Cell Exocytosis Induces Cancer Stem Cell Differentiation by Attenuating Wnt Signaling Pathway},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  doi = {10.1002/adhm.202500778}
}
Kostenlos starten →